| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615361 | Journal of Clinical Lipidology | 2017 | 7 Pages |
Abstract
In a homogeneous population of nondiabetic subjects without lipid-lowering therapy, plasma PCSK9 concentrations are not associated to eGFR at several stages of CKD. These data suggest that kidney function per se does not impact significantly PCSK9 metabolism.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marion PhD, Cédric PhD, Leila MD, Lucie BS, Anne-Marie MD, PhD, Matthieu PharmD, Hélène MD, Lotfi MD, Bernard MD, Jean-Paul MD, PhD, Bertrand MD, PhD,